Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.

Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 ...

Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...

Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...

Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...

TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes ...

The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1 mg demonstrated ...

The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...

Ozempic may be adding some spring to your step — but it might also be taking a bite out of your smile. As the popularity of weight-loss drugs surges, a new concern is emerging: “Ozempic teeth.” ...

If the shoe fits. Ozempic and other weight loss drugs could have a gnarly side effect dubbed “Ozempic-feet,” according to a report. The popular pound-shedding prescription drug is known… ...

The terms “Ozempic face” and “Ozempic butt” are not truly side effects of GLP-1 drugs, but rather consequences that occur from rapid weight loss from the face and rear end.